As first reported in a subscription article at Inside Health Policy, and as summarized open access by McKnights... Seema Verma made some remarks on September 15 about potential new reimbursement paradigms for COVID testing. It seems related to pay-for-performance, but from the quoted remarks, it's difficult to see what any actual change is really being contemplated.
McKnights here open access. Inside Health Policy here subscription.
The headline "hints at new strategy" is about right.
